Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZFGN

Zafgen (ZFGN) Stock Price, News & Analysis

Zafgen logo

About Zafgen Stock (NASDAQ:ZFGN)

Advanced Chart

Key Stats

Today's Range
$3.06
$3.22
50-Day Range
$0.99
$25.06
52-Week Range
$0.62
$2.76
Volume
516,014 shs
Average Volume
360,199 shs
Market Capitalization
$119.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZFGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zafgen and its competitors with MarketBeat's FREE daily newsletter.

ZFGN Stock News Headlines

Tokyo Steel Manufacturing Co Ltd 5423
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Food and drink in a castle
LRMR Larimar Therapeutics, Inc.
Form 424B5 Larimar Therapeutics, - StreetInsider.com
See More Headlines

ZFGN Stock Analysis - Frequently Asked Questions

Zafgen Inc (NASDAQ:ZFGN) posted its earnings results on Thursday, March, 5th. The biopharmaceutical company reported ($0.19) EPS for the quarter, meeting the consensus estimate of ($0.19).

Based on aggregate information from My MarketBeat watchlists, some other companies that Zafgen investors own include Xtrackers California Municipal Bond ETF (CA), Bristol Myers Squibb (BMY), Endologix (ELGX), Energy Transfer (ET), BlackRock (BLK), TG Therapeutics (TGTX) and SCYNEXIS (SCYX).

Company Calendar

Last Earnings
3/05/2020
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZFGN
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.41 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.35 per share
Price / Book
2.37

Miscellaneous

Free Float
N/A
Market Cap
$119.90 million
Optionable
Not Optionable
Beta
0.27
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ZFGN) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners